Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALAN D GLASSMAN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1477592921
CMS profile
202555
Location
VILLA PARK, IL

General Payments · PY2018–2019

$2,152.06

  • Reported across 153 records
  • CMS publication 2026-01-23

Latest program year · PY2019

$589.11

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2019 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $589.11 39

By paying entity

PY2019 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,562.95 114
PY2019 $589.11 39

Payment records · PY2019 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2019 2018 Record-level detail is published for PY2019; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Allergan Inc. $23.67 01/28/2019 Food and Beverage Undisputed 01/23/2026 670418523 CMS
AstraZeneca Pharmaceuticals LP $14.06 01/29/2019 Food and Beverage Undisputed 01/23/2026 685592457 CMS
AstraZeneca Pharmaceuticals LP $12.02 02/13/2019 Food and Beverage Undisputed 01/23/2026 685246259 CMS
AstraZeneca Pharmaceuticals LP $10.98 04/08/2019 Food and Beverage Undisputed 01/23/2026 685733455 CMS
AstraZeneca Pharmaceuticals LP $14.57 04/17/2019 Food and Beverage Undisputed 01/23/2026 686007579 CMS
AstraZeneca Pharmaceuticals LP $12.79 05/06/2019 Food and Beverage Undisputed 01/23/2026 685531341 CMS
AstraZeneca Pharmaceuticals LP $16.73 06/17/2019 Food and Beverage Undisputed 01/23/2026 685821251 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.65 01/15/2019 Food and Beverage Undisputed 01/23/2026 700087343 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.36 05/14/2019 Food and Beverage Undisputed 01/23/2026 700087341 CMS
E.R. Squibb & Sons, L.L.C. $15.92 02/12/2019 Food and Beverage Undisputed 01/23/2026 651257087 CMS
Genentech USA, Inc. $20.46 02/19/2019 Food and Beverage Undisputed 01/23/2026 681362223 CMS
Janssen Pharmaceuticals, Inc $21.59 01/04/2019 Food and Beverage Undisputed 01/23/2026 658634641 CMS
Janssen Pharmaceuticals, Inc $17.28 04/09/2019 Food and Beverage Undisputed 01/23/2026 658634645 CMS
Janssen Pharmaceuticals, Inc $20.57 06/12/2019 Food and Beverage Undisputed 01/23/2026 658634647 CMS
Lilly USA, LLC $14.83 02/20/2019 Food and Beverage Undisputed 01/23/2026 657653245 CMS
Merck Sharp & Dohme Corporation $17.01 02/11/2019 Food and Beverage Undisputed 01/23/2026 695920005 CMS
Novartis Pharmaceuticals Corporation $20.77 03/04/2019 Food and Beverage Undisputed 01/23/2026 659549675 CMS
Novo Nordisk Inc $1.08 01/07/2019 Food and Beverage Undisputed 01/23/2026 682795133 CMS
Novo Nordisk Inc $17.07 01/08/2019 Food and Beverage Undisputed 01/23/2026 668750903 CMS
Novo Nordisk Inc $22.28 01/14/2019 Food and Beverage Undisputed 01/23/2026 668750907 CMS
Novo Nordisk Inc $0.46 01/14/2019 Food and Beverage Undisputed 01/23/2026 682795125 CMS
Novo Nordisk Inc $1.14 03/11/2019 Food and Beverage Undisputed 01/23/2026 682795139 CMS
Novo Nordisk Inc $23.21 03/12/2019 Food and Beverage Undisputed 01/23/2026 669511561 CMS
Novo Nordisk Inc $20.38 04/04/2019 Food and Beverage Undisputed 01/23/2026 669511987 CMS
Novo Nordisk Inc $10.34 04/23/2019 Food and Beverage Undisputed 01/23/2026 669511989 CMS
Novo Nordisk Inc $15.41 05/20/2019 Food and Beverage Undisputed 01/23/2026 669557211 CMS
Novo Nordisk Inc $12.96 05/31/2019 Food and Beverage Undisputed 01/23/2026 669557213 CMS
Novo Nordisk Inc $19.17 06/04/2019 Food and Beverage Undisputed 01/23/2026 674471601 CMS
Novo Nordisk Inc $0.26 06/04/2019 Food and Beverage Undisputed 01/23/2026 682795143 CMS
Novo Nordisk Inc $18.93 06/20/2019 Food and Beverage Undisputed 01/23/2026 674471603 CMS
Novo Nordisk Inc $18.74 09/23/2019 Food and Beverage Undisputed 01/23/2026 674578073 CMS
Novo Nordisk Inc $0.56 09/24/2019 Food and Beverage Undisputed 01/23/2026 682795147 CMS
PFIZER INC. $13.66 02/06/2019 Food and Beverage Undisputed 01/23/2026 671874039 CMS
PFIZER INC. $29.53 04/02/2019 Food and Beverage Undisputed 01/23/2026 671986073 CMS
PFIZER INC. $21.30 05/21/2019 Food and Beverage Undisputed 01/23/2026 672031612 CMS
SANOFI-AVENTIS U.S. LLC $11.57 05/23/2019 Food and Beverage Undisputed 01/23/2026 694048151 CMS
Takeda Pharmaceuticals U.S.A., Inc. $12.00 01/17/2019 Food and Beverage Undisputed 01/23/2026 681806205 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.74 03/25/2019 Food and Beverage Undisputed 01/23/2026 681709157 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.06 06/10/2019 Food and Beverage Undisputed 01/23/2026 681911383 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019
Source files
Dataset page · Bulk file · PY2018 , PY2019
Generated from
OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.